IP
KPTI icon

Intellectus Partners’s Karyopharm Therapeutics KPTI Stock Holding History

Intellectus Partners’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-133
Closed -$12K – 307
2019
Q1 		$12K Buy
133
+80
+151% +$8.87K 0.01% 337
2018
Q4 		$7K Hold
53
– – ﹤0.01% 215
2018
Q3 		$14K Hold
53
– – 0.01% 449
2018
Q2 		$14K Hold
53
– – 0.01% 451
2018
Q1 		$11K Hold
53
– – ﹤0.01% 468
2017
Q4 		$8K Hold
53
– – ﹤0.01% 501
2017
Q3 		$9K Hold
53
– – ﹤0.01% 626
2017
Q2 		$7K Hold
53
– – ﹤0.01% 636
2017
Q1 		$10K Hold
53
– – 0.01% 535
2016
Q4 		$8K Buy
+53
New +$7.17K ﹤0.01% 543

Other funds holding KPTI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return